Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KPI 10

Next Previous
Search
Drug Profile

KPI 10

Alternative Names: KPI-10; WQ-3810; WQ-3813

Latest Information Update: 16 Jul 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wakunaga Pharmaceutical
  • Developer Kalidex Pharmaceuticals
  • Class Antibacterials; Fluoroquinolones
  • Mechanism of Action DNA gyrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Bacterial-infections(In volunteers) in USA (PO)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in USA (IV)
  • 12 Sep 2012 Pharmacokinetic, antimicrobial, and adverse events data from preclinical trials in Bacterial infections presented at the 52nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2012) ,,,

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top